These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 25062081

  • 1. Do apolipoproteins improve coronary risk prediction in subjects with metabolic syndrome? Insights from the North Italian Brianza cohort study.
    Gianfagna F, Veronesi G, Guasti L, Chambless LE, Brambilla P, Corrao G, Mancia G, Cesana G, Ferrario MM.
    Atherosclerosis; 2014 Sep; 236(1):175-81. PubMed ID: 25062081
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study.
    Meisinger C, Loewel H, Mraz W, Koenig W.
    Eur Heart J; 2005 Feb; 26(3):271-8. PubMed ID: 15618061
    [Abstract] [Full Text] [Related]

  • 6. ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects.
    Sierra-Johnson J, Romero-Corral A, Somers VK, Lopez-Jimenez F, Walldius G, Hamsten A, Hellénius ML, Fisher RM.
    Eur Heart J; 2007 Nov; 28(21):2637-43. PubMed ID: 17766927
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Reference intervals for six lipid analytes in 8-14 year-old school children from three different ethnical groups in the Hulun Buir area of China.
    Du Y, Sun H, Li Y, Shi X, Pei D, Qi D, Wang B.
    Clin Lab; 2014 Nov; 60(8):1295-300. PubMed ID: 25185414
    [Abstract] [Full Text] [Related]

  • 9. Interactions of serum hsCRP with apoB, apoB/AI ratio and some components of metabolic syndrome amplify the predictive values for coronary artery disease.
    Rasouli M, Kiasari AM.
    Clin Biochem; 2006 Oct; 39(10):971-7. PubMed ID: 16963013
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The ratio of apoB/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease.
    Rasouli M, Kiasari AM, Mokhberi V.
    Clin Chem Lab Med; 2006 Oct; 44(8):1015-21. PubMed ID: 16879071
    [Abstract] [Full Text] [Related]

  • 14. Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.
    Kappelle PJ, Gansevoort RT, Hillege HJ, Wolffenbuttel BH, Dullaart RP, PREVEND Study Group.
    J Clin Lipidol; 2013 Oct; 7(1):56-64. PubMed ID: 23351584
    [Abstract] [Full Text] [Related]

  • 15. Levels of lipids and apolipoproteins in three cultures.
    Solhpour A, Parkhideh S, Sarrafzadegan N, Asgary S, Williams K, Jungner I, Aastveit A, Walldius G, Sniderman A.
    Atherosclerosis; 2009 Nov; 207(1):200-7. PubMed ID: 19766218
    [Abstract] [Full Text] [Related]

  • 16. Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.
    Robinson JG, Ballantyne CM, Hsueh WA, Rosen JB, Lin J, Shah AK, Tomassini JE, Lowe RS, Tershakovec AM.
    J Clin Lipidol; 2013 Nov; 7(4):292-303. PubMed ID: 23890516
    [Abstract] [Full Text] [Related]

  • 17. Apolipoprotein B, oxidized low-density lipoprotein, and LDL particle size in predicting the incidence of metabolic syndrome: the Cardiovascular Risk in Young Finns study.
    Koskinen J, Magnussen CG, Würtz P, Soininen P, Kangas AJ, Viikari JS, Kähönen M, Loo BM, Jula A, Ahotupa M, Lehtimäki T, Ala-Korpela M, Juonala M, Raitakari OT.
    Eur J Prev Cardiol; 2012 Dec; 19(6):1296-303. PubMed ID: 21960651
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease.
    Sniderman AD, Jungner I, Holme I, Aastveit A, Walldius G.
    J Intern Med; 2006 May; 259(5):455-61. PubMed ID: 16629851
    [Abstract] [Full Text] [Related]

  • 20. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort.
    Mariosa D, Hammar N, Malmström H, Ingre C, Jungner I, Ye W, Fang F, Walldius G.
    Ann Neurol; 2017 May; 81(5):718-728. PubMed ID: 28437840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.